Should Health Systems Share Genetic Findings With At-Risk Relatives When the Proband Is Deceased? Interviews With Individuals Diagnosed With Lynch Syndrome

Overview

Journal J Patient Cent Res Rev

Specialty Health Services

Date 2022 Nov 7

PMID 36340570

Authors

Jessica Ezzell Hunter

Jennifer L Schneider

Alison J Firemark

James V Davis

Sara Gille

Pamala A Pawloski

Su-Ying Liang

Victoria Schlieder

Alanna Kulchak Rahm

Affiliations

Soon will be listed here.

Abstract

Purpose: Genetic information has health implications for patients and their biological relatives. Death of a patient before sharing a genetic diagnosis with at-risk relatives is a missed opportunity to provide important information that could guide interventions to minimize cancer-related morbidity and mortality in relatives.

Methods: We performed semi-structured interviews with individuals diagnosed with Lynch syndrome at 1 of 4 health systems to explore their perspectives on whether health systems should share genetic risk information with relatives following a patient's death. An inductive, open-coding approach was used to analyze audio-recorded content, with software-generated code reports undergoing iterative comparative analysis by a qualitative research team to identify broad themes and representative participant quotes.

Results: Among 23 participating interviewees, 19 supported health systems informing relatives about their Lynch syndrome risk while the remaining 4 were conflicted about patient privacy. Most (n=22) wanted their Lynch syndrome diagnosis shared with relatives if they were unable to share and to be informed of their own risk if a diagnosed relative was unable to share. The most common issues noted regarding information-sharing with relatives included patient privacy and privacy laws (n=8), potential anxiety (n=5), and lack of contact information for relatives (n=3). Interviewee perspectives on how health systems could communicate genetic findings generated a consensus: When - a few months after but within a year of the patient's death; How - explanatory letter and follow-up phone call; and Who - a knowledgeable professional.

Conclusions: Interviews demonstrated strong and consistent perspectives from individuals diagnosed with Lynch syndrome that health systems have a role and responsibility to inform relatives of genetic findings following a patient's death.

References

Dheensa S, Fenwick A, Lucassen A . 'Is this knowledge mine and nobody else's? I don't feel that.' Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Ethics. 2016; 42(3):174-9. PMC: 4789809. DOI: 10.1136/medethics-2015-102781. View

Boers S, van Delden J, Knoers N, Bredenoord A . Postmortem disclosure of genetic information to family members: active or passive?. Trends Mol Med. 2015; 21(3):148-53. DOI: 10.1016/j.molmed.2015.01.002. View

Amendola L, Horike-Pyne M, Trinidad S, Fullerton S, Evans B, Burke W . Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death. J Law Med Ethics. 2015; 43(3):476-85. PMC: 4617192. DOI: 10.1111/jlme.12290. View

Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D . Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006; 66(15):7810-7. DOI: 10.1158/0008-5472.CAN-06-1114. View

Fullerton S, Trinidad S, Jarvik G, Burke W . Beneficence, clinical urgency, and the return of individual research results to relatives. Am J Bioeth. 2012; 12(10):9-10. PMC: 3712902. DOI: 10.1080/15265161.2012.699153. View

Galvin K, Clayman M . Disclosure/disruption: considering why not to disclose genetic information after death. Am J Bioeth. 2012; 12(10):14-6. DOI: 10.1080/15265161.2012.699148. View

Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen L . Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012; 308(15):1555-65. PMC: 3873721. DOI: 10.1001/jama.2012.13088. View

Breitkopf C, Petersen G, Wolf S, Chaffee K, Robinson M, Gordon D . Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank. J Law Med Ethics. 2015; 43(3):464-75. PMC: 4617194. DOI: 10.1111/jlme.12289. View

Heaton T, Chico V . Attitudes towards the sharing of genetic information with at-risk relatives: results of a quantitative survey. Hum Genet. 2015; 135(1):109-20. PMC: 4698294. DOI: 10.1007/s00439-015-1612-z. View

10.

Chan B, Facio F, Eidem H, Hull S, Biesecker L, Berkman B . Genomic inheritances: disclosing individual research results from whole-exome sequencing to deceased participants' relatives. Am J Bioeth. 2012; 12(10):1-8. PMC: 4104597. DOI: 10.1080/15265161.2012.699138. View

11.

Lynch H, Lynch P, Lanspa S, Snyder C, Lynch J, Boland C . Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009; 76(1):1-18. PMC: 2846640. DOI: 10.1111/j.1399-0004.2009.01230.x. View

12.

Bredenoord A, van Delden J . Disclosing individual genetic research results to deceased participants' relatives by means of a qualified disclosure policy. Am J Bioeth. 2012; 12(10):10-2. DOI: 10.1080/15265161.2012.699145. View

13.

Wolf S, Branum R, Koenig B, Petersen G, Berry S, Beskow L . Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations. J Law Med Ethics. 2015; 43(3):440-63. PMC: 4617203. DOI: 10.1111/jlme.12288. View

14.

Breitkopf C, Wolf S, Chaffee K, Robinson M, Lindor N, Gordon D . Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners. J Empir Res Hum Res Ethics. 2018; 13(3):295-304. PMC: 5993615. DOI: 10.1177/1556264618769165. View

15.

Hampel H, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I . Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients. Cancer Res. 2007; 67(19):9603. DOI: 10.1158/0008-5472.CAN-07-2308. View

16.

Rahm A, Cragun D, Hunter J, Epstein M, Lowery J, Lu C . Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts. BMC Health Serv Res. 2018; 18(1):824. PMC: 6208012. DOI: 10.1186/s12913-018-3636-2. View

17.

Allen N, Karlson E, Malspeis S, Lu B, Seidman C, Lehmann L . Biobank participants' preferences for disclosure of genetic research results: perspectives from the OurGenes, OurHealth, OurCommunity project. Mayo Clin Proc. 2014; 89(6):738-46. PMC: 4148696. DOI: 10.1016/j.mayocp.2014.03.015. View

18.

Giardiello F, Allen J, Axilbund J, Boland C, Burke C, Burt R . Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014; 109(8):1159-79. DOI: 10.1038/ajg.2014.186. View